広島大学

基本情報

主な職歴

• 1999年05月, 1999年08月, 京都大学, 医員（研修医）
• 1999年09月, 1999年11月, 国立京都病院, 研修医
• 1999年12月, 2000年09月, 京都大学, 医員（研修医）
• 2000年10月, 2003年03月, 大津赤十字病院, 医師
• 2003年04月, 2004年03月, 市立長浜病院, 医師
• 2004年04月, 2005年03月, 京都大学, 医員
• 2009年02月, 2011年03月, Duke University Medical Center, 研究留学生
• 2011年04月, 2011年09月, 京都大学, 特定病院助教
• 2011年10月, 2013年05月, 日本バプテスト病院, 医師
• 2013年06月, 2013年11月, 京都大学, 特定病院助教
• 2013年11月, 2017年03月, 京都大学, 助教
• 2017年04月, 国立病院機構京都医療センター, 産科婦人科医師
• 2019年03月, 2025年03月, 京都大学, 講師
• 2025年06月01日, 広島大学, 大学院医系科学研究科, 教授

学歴

• 京都大学, 大学院医学研究科, 博士課程婦人科学産科, 日本, 2005年04月, 2009年03月
• 大阪市立大学, 医学部, 医学科, 日本, 1993年04月, 1999年03月

学位

• 博士（医学）　(京都大学)

教育担当

• 【学士課程】 医学部 : 医学科 : 医学プログラム
• 【博士課程】 医系科学研究科 : 医歯薬学専攻 : 医学専門プログラム

研究分野

• 総合生物 / 腫瘍学 / 腫瘍生物学
• 総合生物 / 腫瘍学 / 腫瘍診断学
• 総合生物 / 腫瘍学 / 腫瘍治療学
• 医歯薬学 / 外科系臨床医学 / 産婦人科学

所属学会

• 日本産科婦人科遺伝診療学会, 2026年02月
  関連URL
• 日本女性骨盤底医学会, 2025年11月
  関連URL
• アジア婦人科ロボット手術学会, 2025年04月
• 日本産科婦人科手術学会, 2025年04月
  関連URL
• 日本内視鏡外科学会, 2023年03月
  関連URL
• 日本女性医学学会, 2020年09月
  関連URL
• 日本遺伝カウンセリング学会, 2019年06月
  関連URL
• 日本肉腫学会, 2018年10月
  関連URL
• 日本人類遺伝学会, 2017年08月
  関連URL
• 日本臨床分子形態学会, 2017年04月
  関連URL
• 日本エンドメトリオーシス学会, 2017年01月
  関連URL
• 日本癌学会, 2007年09月
  関連URL
• 日本周産期・新生児医学会, 2011年11月
  関連URL
• 日本婦人科腫瘍学会, 2007年12月
  関連URL
• 日本癌治療学会, 2006年04月
  関連URL
• 日本産科婦人科学会, 1999年04月
  関連URL

教育活動

授業担当

1. 2026年, 学部専門, 通年, 全身性疾患制御学
2. 2026年, 学部専門, 集中, 医学研究実習
3. 2026年, 学部専門, 集中, 臨床実習I
4. 2026年, 教養教育, １ターム, 教養ゼミ
5. 2026年, 博士課程・博士課程後期, セメスター（前期）, 産科婦人科学特別演習
6. 2026年, 博士課程・博士課程後期, セメスター（後期）, 産科婦人科学特別演習
7. 2026年, 博士課程・博士課程後期, セメスター（前期）, 産科婦人科学特別研究
8. 2026年, 博士課程・博士課程後期, セメスター（後期）, 産科婦人科学特別研究
9. 2026年, 博士課程・博士課程後期, セメスター（前期）, 婦人科がん治療演習
10. 2026年, 博士課程・博士課程後期, セメスター（後期）, 婦人科がん治療演習

研究活動

学術論文（★は代表的な論文）

1. ★, HIF2A as a prognostic and clinical therapeutic target in ovarian clear cell carcinoma., Int J Cancer., 158巻, 11号, pp. 2957-2971, 20260601
   DOIを用いた論文検索結果へのリンク
2. Risk stratification of preterm birth using the uterocervical angle and its rate of change in mid- and late-pregnancy: a single-center retrospective study., J Med Ultrason, 20260518
   DOIを用いた論文検索結果へのリンク
3. Photodynamic diagnosis using 5-aminolevulinic acid for detecting residual ovarian cancer within post-chemotherapy scarring: A case report., Photodiagnosis Photodyn Ther., 20260409
   DOIを用いた論文検索結果へのリンク
4. Progressive MRI changes in lobular endocervical glandular hyperplasia suggesting malignant transformation: report of two cases with histopathologic correlation., Abdom Radiol (NY)., 20260309
   DOIを用いた論文検索結果へのリンク
5. Reirradiation for Recurrent Cervical Cancer Within the Previous Radiation Field Using a Bioabsorbable Spacer: A Case Report., J Obstet Gynaecol Res., 52巻, 3号, pp. e70225, 20260306
   DOIを用いた論文検索結果へのリンク
6. Adjuvant Chemotherapy in Stage I Ovarian Clear Cell Carcinoma: A Systematic Review and Meta-analysis., Obstet Gynecol., 147巻, 3号, pp. 344-354, 20260301
   DOIを用いた論文検索結果へのリンク
7. Clinical Characteristics and Predictive Factors of Immune-Mediated Cholangitis: A Large Single-Center Retrospective Observational Study, CANCERS, 18巻, 4号, 20260219
   DOIを用いた論文検索結果へのリンク
8. Digital spatial profiling reveals additive effects of triple therapy on tumor microenvironment: anti-PD-L1, anti-VEGF, and PARP inhibition in mouse models., Cancer Immunol Immunother., 75巻, 3号, pp. 70, 20260207
   DOIを用いた論文検索結果へのリンク
9. Healthcare provider bias in cancer treatment decisions for elderly patients., Taiwan J Obstet Gynecol., 65巻, 1号, pp. 29-33, 20260128
   DOIを用いた論文検索結果へのリンク
10. Oligoclonal B cell expansion and passenger fusion genes predict response to Nivolumab in recurrent ovarian cancer: phase II Kyoto trial., Cancer Immunol Immunother., 75巻, 2号, pp. 52, 20260127
    DOIを用いた論文検索結果へのリンク
11. Possible overestimation of treatment effects of pelvic and para-aortic lymphadenectomy for early-stage ovarian clear cell carcinoma: a retrospective propensity-score weighted multi-center cohort study., J Gynecol Oncol., 37巻, 2号, pp. e24, 20251224
    DOIを用いた論文検索結果へのリンク
12. Real-world application of large language models for automated TNM staging using unstructured gynecologic oncology reports., NPJ Precis Oncol., 9巻, 1号, pp. 366, 20251119
    DOIを用いた論文検索結果へのリンク
13. High-grade gliomas derived from an ovarian mature teratoma: clonal dynamics and genetic insights., Int Cancer Conf J., 14巻, 4号, pp. 421-427, 20250908
    DOIを用いた論文検索結果へのリンク
14. Therapeutic impact of neoadjuvant chemotherapy on lymph node metastasis in locally advanced cervical cancer., J Obstet Gynaecol Res., 52巻, 8号, pp. e70022, 20250828
    DOIを用いた論文検索結果へのリンク
15. Origin of Endometrioid Carcinoma Adjacent to Extraovarian Endometriosis: Detailed Molecular Analyses., Int J Gynecol Pathol., 20250729
    DOIを用いた論文検索結果へのリンク
16. Defecation disorder after anterior pelvic exenteration., J Obstet Gynaecol Res., 51巻, 7号, pp. e16353, 20250727
    DOIを用いた論文検索結果へのリンク
17. A Case of Intramural Adenosarcoma With Sarcomatous Overgrowth Associated With Adenomyosis and Endometriosis., Cureus., 17巻, 7号, pp. e88422, 20250721
    DOIを用いた論文検索結果へのリンク
18. Usefulness of video explanation for informed consent in gynecologic surgery., Int J Gynaecol Obstet., 20250612
    DOIを用いた論文検索結果へのリンク
19. Origin of Peritoneal Cancer With Features of High-grade Serous Carcinoma: A Detailed Molecular Analysis., Int J Gynecol Pathol., 44巻, 3号, pp. 280-285, 20250501
20. Online Live Streaming System for Robotic Surgery With Bidirectional Discussion Through a Commentator: A Multi-Institutional Observational Study., Asian J Endosc Surg., 18巻, 1号, pp. e70072, 20250427
    DOIを用いた論文検索結果へのリンク
21. A Rare Case of Ovarian Serous Borderline Tumor Recurrence with Muscle Metastasis., Am J Case Rep., 26巻, pp. e946680, 20250403
    DOIを用いた論文検索結果へのリンク
22. Awareness and attitude toward cardio-oncology among Japanese gynecologic oncologists in managing patients with endometrial cancer: The Japanese Gynecologic Oncology Group (JGOG) questionnaire surveys., J Obstet Gynaecol Res., 20250205
    DOIを用いた論文検索結果へのリンク
23. Artificial intelligence-based spatial analysis of tertiary lymphoid structures and clinical significance for endometrial cancer., Cancer Immunol Immunother., 74巻, 3号, pp. 84, 20250201
    DOIを用いた論文検索結果へのリンク
24. ★, Changes in Physical Activity Across Cancer Diagnosis and Treatment Based on Smartphone Step Count Data Linked to a Japanese Claims Database: Retrospective Cohort Study., JMIR Cancer., 11巻, pp. e58093, 20250120
    DOIを用いた論文検索結果へのリンク
25. Re-evaluating prognostic factors for cervical cancer with lymph node metastasis: a Japanese multicenter cohort study based on FIGO 2018., Int J Clin Oncol., 20250116
    DOIを用いた論文検索結果へのリンク
26. ★, Prognostic significance of neutrophil-to-lymphocyte ratio, platelet-to-lymphocyte ratio, and monocyte-to-lymphocyte ratio in uterine carcinosarcoma., Int J Clin Oncol., 20250108
    DOIを用いた論文検索結果へのリンク
27. Feasibility/clinical utility of half-Fourier single-shot turbo spin echo imaging combined with deep learning reconstruction in gynecologic magnetic resonance imaging., Abdom Radiol (NY)., 20241218
    DOIを用いた論文検索結果へのリンク
28. ★, Electronic patient-reported outcomes as digital therapeutics for patients with cancer: a narrative review of current practices and future directions., Int J Clin Oncol., 20241216
    DOIを用いた論文検索結果へのリンク
29. Colorectal anastomotic leakage after conversion surgery for advanced endometrial cancer treated with lenvatinib plus pembrolizumab: a case report., Int Cancer Conf J., 14巻, 1号, pp. 64-71, 20241210
30. A stearate-rich diet and oleate restriction directly inhibit tumor growth via the unfolded protein response, Exp Mol Med., 56巻, 12号, pp. 2659-2672, 20241202
31. ★, YAP1 Suppression by ZDHHC7 Is Associated with Ferroptosis Resistance and Poor Prognosis in Ovarian Clear Cell Carcinoma., Mol Cancer Ther., 23巻, 11号, pp. 1652-1665, 20241104
32. Vaginal Cuff Infection Caused by Ureaplasma parvum After Hysterectomy for Uterine Cervical Cancer: A Case Report., Case Rep Infect Dis., 2024巻, pp. 4114954, 20241021
33. SMARCA4-deficient uterine tumors in young women: response to immune checkpoint inhibitors., Int Cancer Conf J., 13巻, 4号, pp. 515-519, 20240917
34. A case of grade1 follicular lymphoma diagnosed by laparoscopic lymph node resection: differentiating from late lymph node recurrence of endometrial cancer., Int Cancer Conf J., 13巻, 4号, pp. 525-531, 20240917
35. A case report of mucinous borderline ovarian tumor with recurrence as invasive carcinoma with high copy number alterations., Int Cancer Conf J., 13巻, 4号, pp. 520-524, 20240917
36. Adjuvant Chemotherapy for Stage I Ovarian Clear Cell Carcinoma., O G Open., 1巻, 3号, pp. 31, 20240912
37. Successful correction of the transverse vaginal septum with a pinhole vaginal foramen using Y-V plasty: A case report., Case Rep Womens Health., 42巻, pp. e00598, 20240327
38. Clinical significance of initial symptoms in endometriosis-associated ovarian cancer., Turk J Obstet Gynecol., 42巻, 1号, pp. 28-36, 20240304
39. Imiquimod for Cervical and Vaginal Intraepithelial Neoplasia: A Systematic Review and Meta-analysis., Obstet Gynecol., 142巻, 2号, pp. 307-318, 20230801
40. Time-Dependent Changes in Risk of Progression During Use of Bevacizumab for Ovarian Cancer., JAMA Netw Open., 6巻, 8号, pp. e2326834, 20230801
41. Investigation of the Effect of Puncture Order and Position on the Difficulty of Lower and Middle Abdominal Port Placement., Gynecol Minim Invasive Ther., 12巻, 4号, pp. 218-224, 20230731
42. A case of solitary lymph node recurrence 9 years after initial treatment for advanced premenopausal endometrioid endometrial cancer; clinical usefulness of hormonal replacement therapy., Int Cancer Conf J., 12巻, 3号, pp. 168-172, 20230310
43. ★, ATM mutation in aggressive uterine adenosarcoma in which systemic chemotherapies had remarkable effects., Int Cancer Conf J., 12巻, 2号, pp. 120-125, 20230112
44. A case of paraovarian tumor of borderline malignancy with decrease of apparent diffusion coefficient value and marked 18F-fluorodeoxyglucose accumulation., Int Cancer Conf J., 12巻, 2号, pp. 126-130, 20221231
45. Nivolumab for malignant transformation of ovarian mature cystic teratoma., Gynecol Oncol Rep., 44巻, pp. 101115, 20221210
46. Immunosuppressive tumor microenvironment in uterine serous carcinoma via CCL7 signal with myeloid-derived suppressor cells., Carcinogenesis., 43巻, 7号, pp. 647-658, 20220830
47. Clinical Features of Neurodevelopmental Outcomes in Children with Preterm Severe Fetal Growth Restriction: A Retrospective Observational Study., JMA J., 5巻, 3号, pp. 341-348, 20220715
48. CXCL13-producing CD4+ T cells accumulate in the early phase of tertiary lymphoid structures in ovarian cancer., JCI Insight., 7巻, 12号, pp. e157215, 20220622
49. Superradical Hysterectomy for Cervical Cancer as an Alternative to the Usual Okabayashi-Type Radical Hysterectomy., Surg J (N Y)., 7巻, Suppl 2号, pp. S108-S114, 20211022
50. Laparoscopic hysterectomy for endometrial cancer after the Fontan procedure: The first case report., Int Cancer Conf J., 11巻, 1号, pp. 41-45, 20211009
51. Tumor Immune Microenvironment during Epithelial-Mesenchymal Transition., Clin Cancer Res., 27巻, 17号, pp. 4669-4679, 20210901
52. A Case of Torsion in an Otherwise-Normal Ovary with a Giant Hematosalpinx Larger than Enlarged Ovary: Utilization of Diagnostic Laparoscopy for the Accurate Diagnosis., Case Rep Obstet Gynecol., 2021巻, pp. 1371611, 20210823
53. A 36 kg Giant Ovarian Fibroma with Meigs Syndrome: A Case Report and Literature Review of Extremely Giant Ovarian Tumor., Case Rep Obstet Gynecol., 2021巻, pp. 1076855, 20210815
54. Combination of gene set signatures correlates with response to nivolumab in platinum-resistant ovarian cancer., Sci Rep., 11巻, 1号, pp. 11427, 20210601
55. ★, Acquired Evolution of Mitochondrial Metabolism Regulated by HNF1B in Ovarian Clear Cell Carcinoma., Cancers (Basel)., 13巻, 10号, pp. 2413, 20210517
56. Sebaceous carcinoma of the vulva treated with sentinel lymph node biopsy: a case report and literature review., Int Cancer Conf J., 10巻, 3号, pp. 239-243, 20210505
57. Three cases of seromucinous carcinoma of the ovary arising in endometriotic cysts., Int Cancer Conf J., 10巻, 1号, pp. 46-53, 20200921
58. UGT1A1 polymorphism has a prognostic effect in patients with stage IB or II uterine cervical cancer and one or no metastatic pelvic nodes receiving irinotecan chemotherapy: a retrospective study., BMC Cancer., 20巻, 1号, pp. 729, 20200805
59. Low-Grade Endometrial Stromal Sarcoma with a Nodule-in-Nodule Appearance in Preoperative Magnetic Resonance Images., Case Rep Obstet Gynecol., 2020巻, pp. 8973262, 20200730
60. Full-term low birth weight infants have differentially hypermethylated DNA related to immune system and organ growth: a comparison with full-term normal birth weight infants., BMC Res Notes., 13巻, 1号, pp. 199, 20200403
61. Anti-VEGF therapy resistance in ovarian cancer is caused by GM-CSF-induced myeloid-derived suppressor cell recruitment., Br J Cancer., 122巻, 6号, pp. 778-788, 20200114
62. Acquisition of a side population fraction augments malignant phenotype in ovarian cancer., Sci Rep., 9巻, 1号, pp. 14215, 20191002
63. Phosphorylation of STAT1 serine 727 enhances platinum resistance in uterine serous carcinoma., Int J Cancer., 145巻, 6号, pp. 1635-1647, 20190915
64. ★, Primary retroperitoneal squamous cell carcinoma: a case report with review of the literature., Int Cancer Conf J., 8巻, 2号, pp. 61-65, 20190123
65. The effect of the type of dietary protein on the development of ovarian cancer., Oncotarget., 9巻, 35号, pp. 23987-23999, 20180508
66. Snail promotes ovarian cancer progression by recruiting myeloid-derived suppressor cells via CXCR2 ligand upregulation., Nat Commun., 9巻, 1号, pp. 1685, 20180427
67. ★, Two cases of recurrent uterine cervical cancer with arterio-enteric fistula treated by femoro-femoral artery bypass in hybrid operation room., Int Cancer Conf J., 7巻, 1号, pp. 26-29, 20171031
68. Four cases of endometrioid borderline ovarian tumour: case reports and literature review., BJR Case Rep., 4巻, 1号, pp. 20170062, 20171021
69. ★, Distinct preoperative clinical features predict four histopathological subtypes of high-grade serous carcinoma of the ovary, fallopian tube, and peritoneum., BMC Cancer., 17巻, 1号, pp. 580, 20170829
70. Combination of Aprepitant, Azasetron, and Dexamethasone as Antiemetic Prophylaxis in Women with Gynecologic Cancers Receiving Paclitaxel/Carboplatin Therapy., Med Sci Monit., 23巻, pp. 826-833, 20170215
71. Expression of Vascular Endothelial Growth Factor in Ovarian Cancer Inhibits Tumor Immunity through the Accumulation of Myeloid-Derived Suppressor Cells., Clin Cancer Res., 23巻, 2号, pp. 587-599, 20170115
72. ★, Comprehensive assessment of the expression of the SWI/SNF complex defines two distinct prognostic subtypes of ovarian clear cell carcinoma., Oncotarget., 7巻, 34号, pp. 54758-54770, 20160823
73. Suppression of ABHD2, identified through a functional genomics screen, causes anoikis resistance, chemoresistance and poor prognosis in ovarian cancer., Oncotarget., 7巻, 30号, pp. 47620-47636, 20160726
74. Chemotherapy Induces Programmed Cell Death-Ligand 1 Overexpression via the Nuclear Factor-κB to Foster an Immunosuppressive Tumor Microenvironment in Ovarian Cancer., Cancer Res., 75巻, 23号, pp. 5034-5045, 20151201
75. Safety and Antitumor Activity of Anti-PD-1 Antibody, Nivolumab, in Patients With Platinum-Resistant Ovarian Cancer., J Clin Oncol., 33巻, 34号, pp. 4015-4022, 20151201
76. Genomic profile predicts the efficacy of neoadjuvant chemotherapy for cervical cancer patients., BMC Cancer., 15巻, pp. 739, 20151019
77. ★, Ovarian clear cell carcinoma meets metabolism; HNF-1β confers survival benefits through the Warburg effect and ROS reduction., Oncotarget., 6巻, 31号, pp. 30704-30714, 20151013
78. ★, Epigenetic and genetic dispositions of ovarian carcinomas., Oncoscience., 1巻, 9号, pp. 574-579, 20150922
79. ★, Metabolic alterations caused by HNF1β expression in ovarian clear cell carcinoma contribute to cell survival., Oncotarget., 6巻, 28号, pp. 26002-26017, 20150922
80. IFN-γ from lymphocytes induces PD-L1 expression and promotes progression of ovarian cancer., Br J Cancer., 112巻, 9号, pp. 1501-1509, 20150428
81. Clinical approaches to treating papillary squamous cell carcinoma of the uterine cervix., BMC Cancer., 14巻, pp. 784, 20141027
82. STAT1 drives tumor progression in serous papillary endometrial cancer., Cancer Res., 74巻, 22号, pp. 6519-6530, 20141015
83. ★, Epigenetic determinants of ovarian clear cell carcinoma biology., Int J Cancer., 135巻, 3号, pp. 585-597, 20140801
84. PD-L1 on tumor cells is induced in ascites and promotes peritoneal dissemination of ovarian cancer through CTL dysfunction., Clin Cancer Res., 19巻, 6号, pp. 1363-1374, 20130315
85. The activated transforming growth factor-beta signaling pathway in peritoneal metastases is a potential therapeutic target in ovarian cancer., Int J Cancer., 130巻, 1号, pp. 20-28, 20120101
86. ★, Ovarian clear cell carcinoma as a stress-responsive cancer: influence of the microenvironment on the carcinogenesis and cancer phenotype., Cancer Lett., 310巻, 2号, pp. 129-133, 20111128
87. Targeting slow-proliferating ovarian cancer cells., Int J Cancer., 126巻, 10号, pp. 2448-2456, 20100515
88. ★, Identification of an ovarian clear cell carcinoma gene signature that reflects inherent disease biology and the carcinogenic processes., Oncogene., 29巻, 12号, pp. 1741-1752, 20100325
89. ★, Contents of endometriotic cysts, especially the high concentration of free iron, are a possible cause of carcinogenesis in the cysts through the iron-induced persistent oxidative stress., Clin Cancer Res., 14巻, 1号, pp. 32-40, 20080101
90. Programmed cell death 1 ligand 1 and tumor-infiltrating CD8+ T lymphocytes are prognostic factors of human ovarian cancer., Proc Natl Acad Sci U S A., 104巻, 9号, pp. 3360-3365, 20070227
91. Comparison of nedaplatin and cisplatin in concurrent chemoradiotherapy for cervical cancer: a systematic review and meta-analysis, INTERNATIONAL JOURNAL OF CLINICAL ONCOLOGY, 31巻, 3号, pp. 537-547, 202603
    DOIを用いた論文検索結果へのリンク
92. Real-world application of comprehensive genomic profiling for gynecological malignancies: a multicenter observational study., Int J Clin Oncol., 29巻, 12号, pp. 1967-1976, 202412
93. Proposal for Managing Cancer-Related Insomnia: A Systematic Literature Review of Associated Factors and a Narrative Review of Treatment., Cancer Med., 13巻, 22号, pp. e70365, 202411
94. Investigation of the clinical implications of anterior cervical invasion in locally advanced cervical squamous cell carcinoma., J Obstet Gynaecol Res., 50巻, 9号, pp. 1581-1590, 202409
95. A deep learning-based assessment pipeline for intraepithelial and stromal tumor-infiltrating lymphocytes in high-grade serous ovarian carcinoma., Am J Pathol., 194巻, 7号, pp. 1272-1284, 202407
96. Clinical Significance of Serum SCC Levels Before Treatment for Locally Advanced Cervical Squamous Cell Carcinoma., Anticancer Res., 44巻, 5号, pp. 2009-2019, 202405
97. Neuroendocrine carcinoma of the uterine cervix with extensive pagetoid spread pattern., J Obstet Gynaecol Res., 50巻, 4号, pp. 758-763, 202404
98. Endometrial gastric-type mucinous carcinoma: A clinicopathological study of an unfavorable histological type of endometrial carcinoma., Pathol Int., 73巻, 12号, pp. 609-611, 202312
99. ★, Real-world practice of estrogen and progestogen prescriptions in menopausal women in Japan: A descriptive study using a Japanese claims database., J Obstet Gynaecol Res., 49巻, 12号, pp. 2952-2961, 202312
100. High-grade vaginal intraepithelial neoplasia after hysterectomy for high-grade cervical intraepithelial neoplasia: Is hysterectomy a "definitive" treatment compared to conization?, J Obstet Gynaecol Res., 49巻, 9号, pp. 2361-2369, 202309
101. ★, Hormone replacement therapy and cancer risks in perimenopausal women: A retrospective cohort study using a Japanese claims database., J Obstet Gynaecol Res., 49巻, 7号, pp. 1805-1814, 202307
102. ★, Real-world practice of estrogen therapy after surgery for endometrial cancer: a descriptive study using a Japanese claims database., Int J Clin Oncol., 28巻, 3号, pp. 445-453, 202303
103. Versican provides the provisional matrix for uterine spiral artery dilation and fetal growth., Matrix Biol., 115巻, pp. 16-31, 202301
104. Chronic abruption-oligohydramnios sequence (CAOS) revisited: possible implication of premature rupture of membranes., J Matern Fetal Neonatal Med., 35巻, 25号, pp. 6894-6900, 202212
105. Clinical practice guidelines for endometriosis in Japan (The 3rd edition)., J Obstet Gynaecol Res., 48巻, 12号, pp. 2993-3044, 202212
106. ★, Development of healthy lifestyle consciousness index for gynecological cancer patients., Support Care Cancer., 30巻, 9号, pp. 7569-7574, 202209
107. Peritoneal dissemination of high-grade serous ovarian cancer: pivotal roles of chromosomal instability and epigenetic dynamics., J Gynecol Oncol., 33巻, 5号, pp. e83, 202209
108. Mutation burden-orthogonal tumor genomic subtypes delineate responses to immune checkpoint therapy., J Immunother Cancer., 10巻, 7号, pp. e004831, 202207
109. Tertiary lymphoid structures are associated with favorable survival outcomes in patients with endometrial cancer., Cancer Immunol Immunother., 71巻, 6号, pp. 1431-1442, 202206
110. MR findings of polypoid endometriosis of female genital organs: report of three cases., Abdom Radiol (NY)., 47巻, 6号, pp. 1968-1974, 202206
111. Utility of Homologous Recombination Deficiency Biomarkers Across Cancer Types., JCO Precis Oncol., 6巻, pp. e2200085, 202205
112. The effect of celecoxib for treatment of preterm labor on fetuses during the second trimester of pregnancy: A pilot case series., Taiwan J Obstet Gynecol., 61巻, 2号, pp. 277-281, 202203
113. ★, Visceral-to-subcutaneous fat ratio is a possible prognostic factor for type 1 endometrial cancer., Int J Clin Oncol., 27巻, 2号, pp. 434-440, 202202
114. ★, Fertility preservation of polypoid endometriosis: Case series and literature review., J Obstet Gynaecol Res., 48巻, 2号, pp. 502-509, 202202
115. B7-H3 Suppresses Antitumor Immunity via the CCL2-CCR2-M2 Macrophage Axis and Contributes to Ovarian Cancer Progression., Cancer Immunol Res., 10巻, 1号, pp. 56-69, 202201
116. Feasibility of Laparoscopic Para-Aortic Lymphadenectomy for Locally Advanced Cervical Cancer., JSLS., 26巻, 1号, pp. e2021.00096, 202201
117. ★, PDK2 leads to cisplatin resistance through suppression of mitochondrial function in ovarian clear cell carcinoma., Cancer Sci., 112巻, 11号, pp. 4627-4640, 202111
118. CT scan assessment of intrauterine balloon tamponade failure for the treatment of atonic postpartum haemorrhage: implications for treatment., BJOG., 128巻, 11号, pp. 1726-1731, 202110
119. A Novel Direct Approach to the Deep Uterine Vein in Laparoscopic Radical Hysterectomy., J Minim Invasive Gynecol., 28巻, 8号, pp. 1444-1445, 202108
120. Survey of the clinical practice pattern of using sentinel lymph node biopsy in patients with gynecological cancers in Japan: the Japan Society of Gynecologic Oncology study., Int J Clin Oncol., 26巻, 5号, pp. 971-979, 202105
121. Potential Novel Ovarian Cancer Treatment Targeting Myeloid-Derived Suppressor Cells., Cancer Invest., 39巻, 4号, pp. 310-314, 202104
122. ★, Serum lactate dehydrogenase is a possible predictor of platinum resistance in ovarian cancer., Obstet Gynecol Sci., 63巻, 6号, pp. 709-718, 202011
123. New method for determining fibrinogen and FDP threshold criteria by artificial intelligence in cases of massive hemorrhage during delivery., J Obstet Gynaecol Res., 46巻, 2号, pp. 256-265, 202002
124. Association between socioeconomic status and small-for-gestational-age in Japan: A single center retrospective cohort study., J Obstet Gynaecol Res., 46巻, 1号, pp. 110-118, 202001
125. Thoracoscopic Resection of Fluorodeoxyglucose-Avid Mediastinal Lymph Nodes Associated with Advanced Ovarian Carcinoma., Thorac Cardiovasc Surg., 67巻, 8号, pp. 692-696, 201912
126. High-intensity breastfeeding improves insulin sensitivity during early post-partum period in obese women with gestational diabetes., Diabetes Metab Res Rev., 35巻, 4号, pp. e3127, 201905
127. ★, Mucinous adenocarcinoma, gastric type of the uterine cervix: clinical features and HER2 amplification., Med Mol Morphol., 52巻, 1号, pp. 52-59, 201903
128. VISTA expressed in tumour cells regulates T cell function., Br J Cancer., 120巻, 1号, pp. 115-127, 201901
129. Prevalence and Risk Factors of Elevated Liver Enzymes in Japanese Women With Polycystic Ovary Syndrome., J Clin Med Res., 10巻, 12号, pp. 904-910, 201812
130. Antitumor Effect of Nivolumab on Subsequent Chemotherapy for Platinum-Resistant Ovarian Cancer., Oncologist., 23巻, 11号, pp. 1382-1384, 201811
131. Invasive Paget's disease of the vulva treated with a combination of surgery and concurrent chemoradiotherapy: A case report., Mol Clin Oncol., 9巻, 5号, pp. 489, 201811
132. Exome Sequencing Landscape Analysis in Ovarian Clear Cell Carcinoma Shed Light on Key Chromosomal Regions and Mutation Gene Networks., Am J Pathol., 187巻, 10号, pp. 2246-2258, 201710
133. ★, Unenhanced region on magnetic resonance imaging represents tumor progression in uterine carcinosarcoma., J Gynecol Oncol., 28巻, 5号, pp. e62, 201709
134. ★, Groin lymph node detection and sentinel lymph node biopsy in vulvar cancer., J Gynecol Oncol., 27巻, 6号, pp. e57, 201611
135. [Perspectives of Individualized Treatment by Genome-Wide Analyses in Ovarian Cancer]., Gan To Kagaku Ryoho., 43巻, 11号, pp. 1316-1320, 201611
136. Two cases of Wolffian tumor with novel magnetic resonance imaging findings reflecting characteristic pathology., J Obstet Gynaecol Res., 42巻, 8号, pp. 1046-1051, 201608
137. Significance of histologic pattern of carcinoma and sarcoma components on survival outcomes of uterine carcinosarcoma., Ann Oncol., 27巻, 7号, pp. 1257-1266, 201607
138. Establishment of a Novel Histopathological Classification of High-Grade Serous Ovarian Carcinoma Correlated with Prognostically Distinct Gene Expression Subtypes., Am J Pathol., 186巻, 5号, pp. 1103-1113, 201605
139. ★, Magnetic resonance imaging findings and prognosis of gastric-type mucinous adenocarcinoma (minimal deviation adenocarcinoma or adenoma malignum) of the uterine corpus: Two case reports., Mol Clin Oncol., 4巻, 5号, pp. 699-704, 201605
140. The BMP signaling pathway leads to enhanced proliferation in serous ovarian cancer-A potential therapeutic target., Mol Carcinog., 55巻, 4号, pp. 335-345, 201604
141. Clinical efficacy of neoadjuvant chemotherapy with irinotecan (CPT-11) and nedaplatin followed by radical hysterectomy for locally advanced cervical cancer., J Int Med Res., 44巻, 2号, pp. 346-356, 201604
142. Prediction of taxane and platinum sensitivity in ovarian cancer based on gene expression profiles., Gynecol Oncol., 141巻, 1号, pp. 49-56, 201604
143. Menstrual cyclic change of metastin/GPR54 in endometrium., Med Mol Morphol., 48巻, 2号, pp. 76-84, 201506
144. ★, Hepatocyte nuclear factor-1β (HNF-1β) promotes glucose uptake and glycolytic activity in ovarian clear cell carcinoma., Mol Carcinog., 54巻, 1号, pp. 35-49, 201501
145. Invasion of uterine cervical squamous cell carcinoma cells is facilitated by locoregional interaction with cancer-associated fibroblasts via activating transforming growth factor-beta., Gynecol Oncol., 136巻, 1号, pp. 104-111, 201501
146. Clear cell carcinoma arising from a uterus-like mass., Pathol Int., 64巻, 11号, pp. 576-580, 201411
147. Two cases of recurrent ovarian clear cell carcinoma treated with sorafenib., Cancer Biol Ther., 15巻, 1号, pp. 22-25, 201401
148. A novel diagnostic criterion for lymph node metastasis in cervical cancer using multi-detector computed tomography., Gynecol Oncol., 131巻, 3号, pp. 701-707, 201312
149. Utilization of genomic signatures to identify high-efficacy candidate drugs for chemorefractory endometrial cancers., Int J Cancer., 133巻, 9号, pp. 2234-2244, 201310
150. Ileal perforation and massive intestinal haemorrhage from endometriosis in pregnancy: case report and literature review., Eur J Obstet Gynecol Reprod Biol., 170巻, 1号, pp. 20-24, 201309
151. Expression pattern of Galectin 4 in rat placentation., Placenta., 33巻, 10号, pp. 885-887, 201210
152. ★, Clinical management of ovarian endometriotic cyst（chocolate cyst）：diagnosis, medical treatment, and minimally invasive surgery., Curr Obstet Gynecol Rep., pp. 16-24, 201201
153. Sorafenib efficacy in ovarian clear cell carcinoma revealed by transcriptome profiling., Cancer Sci., 101巻, 12号, pp. 2658-2663, 201012
154. Activated local immunity by CC chemokine ligand 19-transduced embryonic endothelial progenitor cells suppresses metastasis of murine ovarian cancer., Stem Cells., 28巻, 1号, pp. 164-173, 201001
155. ★, Ovarian cancer in endometriosis: molecular biology, pathology, and clinical management., Int J Clin Oncol., 14巻, 5号, pp. 383-391, 200910
156. Clinical significance of the NKG2D ligands, MICA/B and ULBP2 in ovarian cancer: high expression of ULBP2 is an indicator of poor prognosis., Cancer Immunol Immunother., 58巻, 5号, pp. 641-652, 200905
157. ★, Malignant transformation of mature cystic teratoma of the ovary including three cases occurring during follow-up period., Oncol Rep., 19巻, 3号, pp. 705-711, 200803
158. Immunostimulatory effect of Fms-like tyrosine kinase 3 ligand on peripheral monocyte-derived dendritic cells and natural killer cells: utilization for ovarian cancer treatment., Oncol Rep., 19巻, 2号, pp. 505-515, 200802
159. Immortalized ovarian surface epithelial cells acquire tumorigenicity by Acrogranin gene overexpression., Oncol Rep., 17巻, 2号, pp. 329-333, 200702
160. ★, Postpartum hemorrhage is associated with neonatal body weight, pre-pregnancy body mass index, and maternal weight gain., Clin. Exp. Obstet. Gynecol., 47巻, 6号, pp. 820-925, 2020
161. Association of Dietary Change during Pregnancy with Large-for-Gestational Age Births: A Prospective Observational Study., J Nutr Sci Vitaminol (Tokyo)., 66巻, 3号, pp. 246-254, 2020
162. Tight systolic blood pressure control early in pregnancy improves pregnancy outcomes in women with chronic hypertension., Hypertension Research in Pregnancy., 7巻, 2号, pp. 75-81, 2019

受賞

1. 2023年09月30日, 日本臨床分子形態学会　最多査読賞, 日本臨床分子形態学会
2. 2022年11月05日, 日本臨床分子形態学会　最多査読賞, 日本臨床分子形態学会
3. 2019年04月12日, 第71回日本産科婦人科学会学術講演会シンポジウム1（腫瘍）, 日本産科婦人科学会
4. 2015年04月12日, 日本産科婦人科学会学術講演会　優秀演題賞（婦人科腫瘍学部門）, 日本産科婦人科学会
5. 2011年06月25日, 日本産科婦人科学会学術講演会　優秀論文賞（婦人科腫瘍学部門）, 日本産科婦人科学会
6. 2009年04月05日, 日本産科婦人科学会学術講演会　優秀演題賞（婦人科腫瘍学部門）, 日本産科婦人科学会

社会活動

委員会等委員歴

1. 子宮がん専門委員会委員, 2025年11月, 2026年03月, （財）広島県地域保健医療推進機構
2. 医師確保対策専門委員会委員, 2025年07月, 2027年03月, 広島県地域保健対策協議会
3. 周産期・小児医療協議会委員, 2025年07月, 2027年03月, 広島県